English

CIRCA PHARMACEUTICALS INC

EDGAR

Annual report amendment (10-K/A) · filed 1995-06-13

12 filing records in this dataset, filed from 1994-04-29 to 1995-06-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

7.92 million USD

1995-03-31 · USD

Exact inputs and evidence

Revenue: 7917000 USD Source

Operating margin

16.05%

1995-03-31 · %

Exact inputs and evidence

Operating Income: 1271000 USD Source
Revenue: 7917000 USD Source

Operating cash flow

4.11 million USD

1995-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 4106000 USD Source

Free cash flow

2.93 million USD

1995-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 4106000 USD Source
Capital Expenditure: 1179000 USD Source

Cash and cash equivalents: 23.1 million USD 1995-03-31 Source
Exact value

23070000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1995-06-13.

Financial data available through: 1994-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 1994-12-31
Operating income: 3 of 11 periods available· newest 1994-12-31
Net income: 3 of 11 periods available· newest 1994-12-31
Operating cash flow: 3 of 11 periods available· newest 1994-12-31
capital expenditure: No compatible figures in this window
Total assets: 2 of 11 periods available· newest 1994-12-31
liabilities: No compatible figures in this window
Current assets: 2 of 11 periods available· newest 1994-12-31
Current liabilities: 2 of 11 periods available· newest 1994-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 1994-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+137%

Prior period

USD 3.29 million

1993-01-01 – 1993-12-31
Current period

USD 7.8 million

1994-01-01 – 1994-12-31

Exact inputs and evidence

7801481 − 3291280 = 4510201 USD

3291280 USD · 1993-01-01 – 1993-12-31
Inspect prior input Prior source
7801481 USD · 1994-01-01 – 1994-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CIRCA PHARMACEUTICALS INC · 1994-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Year-over-year change in Revenue: 4510201 USD Concept: fundies:Revenue Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7801481 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#984 Input fundies:Revenue: 3291280 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#984
The citation records this snapshot. The page link may show a newer release later.
Net income
+105.6%

Prior period

USD 8.4 million

1993-01-01 – 1993-12-31
Current period

USD 17.26 million

1994-01-01 – 1994-12-31

Exact inputs and evidence

17259045 − 8395248 = 8863797 USD

8395248 USD · 1993-01-01 – 1993-12-31
Inspect prior input Prior source
17259045 USD · 1994-01-01 – 1994-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CIRCA PHARMACEUTICALS INC · 1994-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Year-over-year change in Net income: 8863797 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 17259045 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1041 Input fundies:NetIncome: 8395248 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1041
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 531,913

Prior period

−USD 4.56 million

1993-01-01 – 1993-12-31
Current period

−USD 4.03 million

1994-01-01 – 1994-12-31

Exact inputs and evidence

-4026847 − -4558760 = 531913 USD

-4558760 USD · 1993-01-01 – 1993-12-31
Inspect prior input Prior source
-4026847 USD · 1994-01-01 – 1994-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CIRCA PHARMACEUTICALS INC · 1994-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Year-over-year change in Operating cash flow: 531913 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4026847 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1080 Input fundies:OperatingCashFlow: -4558760 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1080
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1994 1994-01-01 – 1994-12-31

Revenue USD 7.8 million 100% of revenue
Cost of revenue USD 3.63 million 47% of revenue
Operating expenses USD 15.54 million 199% of revenue
Other operating costs Derived USD 3.96 million 51% of revenue
Operating income −USD 15.33 million −196% of revenue
Tax, interest and other Derived −USD 32.59 million −418% of revenue
Net income USD 17.26 million 221% of revenue

Cash

Operating cash flow −USD 4.03 million −52% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1992 Operating loss: operating costs were 20,419% of revenue.
1993 Operating loss: operating costs were 672% of revenue.
1994 Operating loss: operating costs were 296% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1992 1992-01-01 – 1992-12-31	89015	18176183 Derived	-18087168	-8402308 Derived	-9684860	Unavailable	Source 1992-01-01 – 1992-12-31: 89015 USD Inspect Revenue Open source 1992-01-01 – 1992-12-31: -18087168 USD Inspect Operating Income Open source 1992-01-01 – 1992-12-31: -9684860 USD Inspect Net Income Open source 1992-01-01 – 1992-12-31: 12492734 USD Inspect Operating Cash Flow Open source
1993 1993-01-01 – 1993-12-31	3291280	22107575 Derived	-18816295	-27211543 Derived	8395248	Unavailable	Source 1993-01-01 – 1993-12-31: 3291280 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: -18816295 USD Inspect Operating Income Open source 1993-01-01 – 1993-12-31: 8395248 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: -4558760 USD Inspect Operating Cash Flow Open source
1994 1994-01-01 – 1994-12-31	7801481	23128394 Derived	-15326913	-32585958 Derived	17259045	Unavailable	Source 1994-01-01 – 1994-12-31: 7801481 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -15326913 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: 17259045 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -4026847 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.8M 1994

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19921992-12-31	Revenue	89015	Revenue: 89015 Open source
19931993-12-31	Revenue	3291280	Revenue: 3291280 Open source
19941994-12-31	Revenue	7801481	Revenue: 7801481 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

137% 1994

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19921992-12-31	Year over year	No prior comparable period	Revenue: 89015 Open source
19931993-12-31	Year over year	3,597.4%	Revenue: 3291280 Open source Revenue: 89015 Open source
19941994-12-31	Year over year	137%	Revenue: 7801481 Open source Revenue: 3291280 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -196.5% 1994

Net margin 221.2% 1994

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19921992-12-31	Operating margin	-20,319.2%	Operating Income: -18087168 Open source Revenue: 89015 Open source
19931993-12-31	Operating margin	-571.7%	Operating Income: -18816295 Open source Revenue: 3291280 Open source
19941994-12-31	Operating margin	-196.5%	Operating Income: -15326913 Open source Revenue: 7801481 Open source
19921992-12-31	Net margin	-10,880%	Net Income: -9684860 Open source Revenue: 89015 Open source
19931993-12-31	Net margin	255.1%	Net Income: 8395248 Open source Revenue: 3291280 Open source
19941994-12-31	Net margin	221.2%	Net Income: 17259045 Open source Revenue: 7801481 Open source
19921992-12-31	Free cash flow margin	Not reported	Revenue: 89015 Open source Operating Cash Flow: 12492734 Open source
19931993-12-31	Free cash flow margin	Not reported	Revenue: 3291280 Open source Operating Cash Flow: -4558760 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 7801481 Open source Operating Cash Flow: -4026847 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4M 1994

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19921992-12-31	Operating cash flow	12492734	Operating Cash Flow: 12492734 Open source
19931993-12-31	Operating cash flow	-4558760	Operating Cash Flow: -4558760 Open source
19941994-12-31	Operating cash flow	-4026847	Operating Cash Flow: -4026847 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19921992-12-31	Free cash flow	Unavailable	Operating Cash Flow: 12492734 Open source
19931993-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4558760 Open source
19941994-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4026847 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1992-12-31	Liabilities / assets	Not reported	No source recorded
1993-12-31	Liabilities / assets	Not reported	Total Assets: 102409285 Open source
1994-12-31	Liabilities / assets	Not reported	Total Assets: 103857000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

9.27× 1994

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1992-12-31	Current assets / current liabilities	Not reported	No source recorded
19931993-12-31	Current assets / current liabilities	3.68×	Current Assets: 47828864 Open source Current Liabilities: 13011998 Open source
19941994-12-31	Current assets / current liabilities	9.27×	Current Assets: 57656000 Open source Current Liabilities: 6218615 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1992 1992-01-01 – 1992-12-31	−USD 9.68 million Exact value Exact value: -9684860 USD 1992-01-01 – 1992-12-31: -9684860 USD Inspect Net Income Open source Share or cite Citation for Net Income · CIRCA PHARMACEUTICALS INC · 1992-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Net Income: -9684860 USD Concept: fundies:NetIncome Period: 1992-01-01 to 1992-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006/explain?concept=fundies%3ANetIncome&period=1992-12-31&surface=latest&period_type=duration&start=1992-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9684860 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1041 The citation records this snapshot. The page link may show a newer release later.	USD 12.49 million Exact value Exact value: 12492734 USD 1992-01-01 – 1992-12-31: 12492734 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CIRCA PHARMACEUTICALS INC · 1992-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Operating Cash Flow: 12492734 USD Concept: fundies:OperatingCashFlow Period: 1992-01-01 to 1992-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006/explain?concept=fundies%3AOperatingCashFlow&period=1992-12-31&surface=latest&period_type=duration&start=1992-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12492734 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1080 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1993 1993-01-01 – 1993-12-31	USD 8.4 million Exact value Exact value: 8395248 USD 1993-01-01 – 1993-12-31: 8395248 USD Inspect Net Income Open source Share or cite Citation for Net Income · CIRCA PHARMACEUTICALS INC · 1993-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Net Income: 8395248 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8395248 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1041 The citation records this snapshot. The page link may show a newer release later.	−USD 4.56 million Exact value Exact value: -4558760 USD 1993-01-01 – 1993-12-31: -4558760 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CIRCA PHARMACEUTICALS INC · 1993-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Operating Cash Flow: -4558760 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4558760 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1080 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1994 1994-01-01 – 1994-12-31	USD 17.26 million Exact value Exact value: 17259045 USD 1994-01-01 – 1994-12-31: 17259045 USD Inspect Net Income Open source Share or cite Citation for Net Income · CIRCA PHARMACEUTICALS INC · 1994-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Net Income: 17259045 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: 17259045 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1041 The citation records this snapshot. The page link may show a newer release later.	−USD 4.03 million Exact value Exact value: -4026847 USD 1994-01-01 – 1994-12-31: -4026847 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CIRCA PHARMACEUTICALS INC · 1994-12-31 CIRCA PHARMACEUTICALS INC (edgar:13006) Operating Cash Flow: -4026847 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-07T10:06:33Z Snapshot: f82c603908c75037dd29fe1b90ae9126563ba9d1eee85e87d1219c7952ad357e Dimensions: Consolidated View: https://fundies.io/companies/edgar/13006/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4026847 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/13006/0000013006-95-000014.txt#1080 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 0000013006, 13006, edgar:13006

CIRCA PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

1994 1994-01-01 – 1994-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation